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Disorders of the Nervous System

CRF Mediates Stress-Induced Pathophysiological
High-Frequency Oscillations in Traumatic Brain
Injury
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and Michael O. Poulter1
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Robarts Research Institute, Schulich School of Medicine, University of Western Ontario, London, Ontario N6A 5K8,
Canada

Abstract
It is not known why there is increased risk to have seizures with increased anxiety and stress after traumatic brain
injury (TBI). Stressors cause the release of corticotropin-releasing factor (CRF) both from the hypothalamic
pituitary adrenal (HPA) axis and from CNS neurons located in the central amygdala and GABAergic interneurons.
We have previously shown that CRF signaling is plastic, becoming excitatory instead of inhibitory after the
kindling model of epilepsy. Here, using Sprague Dawley rats we have found that CRF signaling increased
excitability after TBI. Following TBI, CRF type 1 receptor (CRFR1)-mediated activity caused abnormally large
electrical responses in the amygdala, including fast ripples, which are considered to be epileptogenic. After TBI,
we also found the ripple (120 –250 Hz) and fast ripple activity (⬎250 Hz) was cross-frequency coupled with  (3– 8
Hz) oscillations. CRFR1 antagonists reduced the incidence of phase coupling between ripples and fast ripples.
Our observations indicate that pathophysiological signaling of the CRFR1 increases the incidence of epileptiform
activity after TBI. The use for CRFR1 antagonist may be useful to reduce the severity and frequency of TBI
associated epileptic seizures.
Key words: traumatic brain injury; stress; voltage sensitive dye imaging ripples; epilepsy; rat

Significance Statement
The combination of traumatic brain injury (TBI) and stress is known to increase the likelihood of posttraumatic epilepsy (PTE). Here, we show after moderate TBI that corticotropin-releasing factor (CRF) increases
the excitability of a number of limbic regions in the rat. In particular a tail pinch stress causes epileptiform
activity that is characterized by the occurrence of fast ripples that are phase amplitude coupled to  rhythm.
This activity is blocked by CRF receptor 1 (CRFR1) antagonist. Our data provide a possible mechanism by
which stress exacerbates epileptiform activity.

Introduction
Traumatic brain injury (TBI) refers to injuries that include
concussions, impacts to the head, blast injuries as well as
others (Maas et al., 2008). It affects a wide spectrum of
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individuals in the population regardless of age, background, and health status and is, therefore, a critical
public health problem throughout the world (Langlois and
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Sattin, 2005; Tagliaferri et al., 2006; Maas et al., 2008). TBI
is associated with the development of neurocognitive
deficits, such as impaired attention and depression (30 –
70% of people with TBI develop depression; Roozenbeek
et al., 2013). In particular, mild TBI has been shown to
predispose people to psychiatric disorders, such as anxiety, depression, mood disorders, and disruptive behaviors (Curvis et al., 2016; Emery et al., 2016). Among these
individuals, TBI is also a leading cause of acquired epilepsy (Campbell et al., 2014; Wilson et al., 2017; Xu et al.,
2017; Zimmermann et al., 2017). Compared to general
population, individuals sustaining TBI have on average a
3-fold higher risk of developing epilepsy (Martin et al.,
2014; Rehman et al., 2015; Chen et al., 2017). Epilepsy
has a substantial impact on the quality of life of affected
individuals, and in the United States alone, it has an
estimated cost of approximately $13 billion each year
(Begley and Durgin, 2015). Importantly, heightened anxiety is a precipitating factor for seizure genesis after TBI
(Juengst et al., 2017). How this occurs is not understood,
but it is clear that a cascade of molecular, electrophysiological, and cellular changes initiates myriad outcomes
that result in the development of posttraumatic epilepsy
(PTE; Pitkänen et al., 2014; Lucke-Wold et al., 2015).
Thus, a better understanding of how stressors and TBI
interact to increase the onset of PTE is required. In particular, there are numerous case studies linking TBI to
posttraumatic stress disorder (PTSD; Levin et al., 2001;
Greenspan et al., 2006; Gaylord et al., 2008; Hoge et al.,
2008). The risk of development of epilepsy later in life is
higher in patients with PTSD compared to patients without PTSD (Chen et al., 2017).
Corticotropin-releasing factor (CRF), a 40-amino acid
neuropeptide, is well known to be implicated in stress and
anxiety disorders. It is released in various brain regions
during stress and mediates endocrine/behavioral responses. In normal rats, CRF dampens the excitability of
piriform cortex (PCtx; Narla et al., 2015). This effect is
mediated by CRF receptor 1 (CRFR1) signaling through
the activation of the G-protein, G␣q/11. CRF exacerbates
seizures in a kindling model of epilepsy through the activation of CRFR1 in PCtx (Narla et al., 2016). After kindling,
CRFR1 signals the activation of a different G-protein, G␣s,
and in this case, CRF causes the excitation of overall PCtx
circuitry. Thus, epilepsy altered “the polarity” of a stressor
signal increasing the excitability of the PCtx. Here, we
hypothesize that after TBI, CRF activity changes in a
manner that supports the generation of epileptiform activity during stress. Indeed, we show that TBI alters widespread CRF activity, enhancing network excitability (as in
kindling). CRFR1 activation was responsible for the generation of pathophysiological high-frequency oscillations
(HFOs; ⬎250 Hz; fast ripples) and these oscillations were
Correspondence should be addressed to Michael O. Poulter at
mpoulter@robarts.ca.
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phase-locked with a very large increase in the power of 
activity. Also, we show that CRF activation has a similar
response in the kindling model enhancing the incidence of
fast ripples.

Materials and Methods
Procedures were performed in accordance with the
guidelines of Canadian Council of Animal Care and approved by the University of Western Ontario Animal Care
committee.
TBI procedure
Adult male Sprague Dawley rats weighing 150 –180 g
were used in all of our experiments. They were housed
individually with free access to food and water under a
continuous 12/12 h light/dark cycle. Animals were anesthetized with ketamine-medetomidine hydrochloride combination and placed in a stereotaxic frame for positioning under
a pneumatic impactor (Precision Science Instruments). The
animals were placed under 2% isoflurane to maintain the
anesthesia throughout the surgery. Scalps were shaved, and
rats were placed in a stereotactic apparatus. Eye ointment
(LacriLube) was applied throughout the procedure to prevent irritation and drying. The scalp was scrubbed with
povidone-iodine, a bacteriostat, and 70% ethanol, respectively, with sterile cotton swabs. A 6- to 8-mm longitudinal
incision was made in the scalp, and sterile tissue clamps
were used to hold the incision open to expose the skull. The
fascia was scored and gently removed with a scalpel. Stereotactic coordinates were determined, and a craniotomy
was performed at 2.0 mm anterior to bregma, 4.8 mm lateral
to the midline. A 1-mm hole was drilled through which the
piston was introduced. Animals received a unilateral injury to
the surface of the brain at above-mentioned coordinates.
The injury parameters consisted of 2.5-mm cortical compression at a speed of 3.5 m/s for 500 ms. Sham animals
received a craniotomy but did not receive an impact to the
brain. Following the impact, the skull cap was placed back in
place using Vetbond tissue glue. Stereotactic coordinates
were determined and electrodes were implanted at 2.6 mm
posterior to bregma, 4.8 mm lateral to the midline, and 8.0
mm ventral (Paxinos and Watson, 1986). The electrodes
were made of two twisted strands of 0.127-mm diameter
diamel-insulated nichrome wire and were attached to male
amphenol pins. The electrodes were implanted and secured
to the skull with jeweler’s screws. The electrode assembly
was fixed to the skull by dental acrylic cement (McIntyre and
Molino, 1972). Animals were then removed from isoflurane
anesthesia and placed in a clean cage. The temperature was
maintained at 37°C with the use of a heating pad. Rats were
not used for either slice experiments or in vivo recordings for
a least one week after surgery. During this time rats were
behaviorally monitored to ensure that they were eating and
drinking normally and not exhibiting any sickness behaviors.
All rats used for this study survived the surgery and recovered.
In vitro experiments
Slice preparation
Animals were anesthetized with a ketamine-medetomidine hydrochloride combination and then perfused
eNeuro.org
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through the heart with an ice-cold artificial CSF (ACSF) in
which sodium ions were replaced by choline ions. The
brain was rapidly removed (⬍2 min) and then transferred
into cold choline ACSF. Slices were prepared on vibratome; once sliced, they were warmed to 32°C for 30
min and then transferred to room temperature bath until
they were needed for recordings.
Voltage-sensitive dye imaging (VSDI)
Brain slices from Sprague Dawley rats (six sham and six
TBI) were used for the VSDI recordings. These were 800
m thick and perfused on both sides during recordings.
Slice were incubated in the voltage-sensitive dye Di-4ANEPPS (D-199, Invitrogen Inc.) for 35 min. The stock
solution of the dye was dissolved in ethanol (22 mg/ml).
On the day of experiment, the dye incubation was prepared by mixing 60 l of dye stock with 500 l of fetal
bovine serum (FBS), 500 l of ACSF, and 310 l of 10%
cremophore-EL solution. The concentration of dye in the
final solution was 0.1 mg/ml. After incubation, slices were
washed for 8 –10 min with ACSF and transferred to recording chamber. The temperature of the bath was maintained at 32°C during recordings and continuously
supplied with carbogen-bubbled ACSF having a composition of 110 mM NaCl, 2.5 mM KCl, 1.2 mM NaH2PO4, 25
mM NaHCO3, 2.0 mM CaCl2, 2.0 mM MgCl2, and 20 mM
dextrose. The pH and osmolarity of the solutions were
adjusted to 7.3–7.4 and 297–305 mOsm, respectively.
CRF ACSF was perfused into the recordings chamber for
10 min before a new set of responses were done.
Each VSDI recording was 20 s in length and consisted
of two époques. The first was a 2-s recording of background activity before the stimulus followed by the stimulus application for 1 s with frequencies differing from 5 to
100 Hz. The acquisition rate was between 5 ms/frame. For
each recording minimum camera saturation was set
around 50% while the maximum was ⬃80%. Optical
recording was conducted using a CMOS camera (Micam
Ultima, BrainVision, Inc.) mounted on top of an upright
microscope (Fixed Stage Upright Microscope BX51WI,
Olympus). The light from a 100-W halogen lamp source
(HLX 64625, Microlites Scientific, Corp.) passed through
an excitation filter ( ⫽ 530 ⫾ 10 nm). The fluorescent
signals were collected and projected onto the CMOS
sensor through a long pass emission filter ( ⬎ 590 nm). A
long-distance objective was used in these experiments
(XLFluor 4X N.A. 0.28, Olympus). The movies were recorded and analyzed using Brain Vision Analyzer software. The acquisition settings were: 100 ⫻ 100 pixels
frame size, after magnification each represented 25 ⫻ 25
m space on the brain slice. The dye signal intensity
decreases as the membrane depolarizes. However, to
better match conventional recordings the signals all have
been converted so that the excitatory and inhibitory signals were shown as positive and negative values. The
fractional change in fluorescence signal relative to background signal (⌬F/F) was calculated for each frame of
each recording. For all the recordings, we binned 5 ⫻ 5
pixels into one representative signal this bin was placed in
the three areas of interest. The software locks this area
into place form one recording to the next so exactly the
March/April 2019, 6(2) e0334-18.2019
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same 5 ⫻ 5 bin is compared in each recording. The peak
response was used to compare changes before and after
drug application. For each recording, the bin was placed
in a minimum of three regions within layer II, layer III, and
the endopiriform nucleus; these were averaged to arrive at
a single value that was averaged between differing slice
recordings. As there was considerable variability in the
magnitude of the responses from slice to slice due to
differences in loading of the dye, we normalized the recordings by dividing all signals by the response to the
20-Hz stimuli. This permitted us to average the normalized responses between recordings.
A platinum/iridium electrode (Microprobes, Inc.) with a
tip diameter of 200 –300 m was used to stimulate lateral
olfactory tract (LOT) of PC. The stimulation of each slice
was in the range of 160 –200 A, each square pulse was
2.0 ms in length. The electrode was connected to a
stimulator (S88X dual output square pulse stimulator,
Grass Technologies, Astro-Med, Inc.), which controlled
the pulse frequency and train duration. Recordings were
taken from the anteroposterior portion of the PCtx. Care
was taken that all the layers of PCtx including dorsal
endopiriform nucleus (DEn) and LOT (where the electrode
was placed) appeared explicitly under the camera view.
Drugs were applied for at least 10 min before taking a
respective recording.
In vivo experiments
Tail pinch as a model of stress
Animals were allocated to two groups as sham and TBI
animals. Both groups underwent the tail pinch protocol.
During this protocol, an animal was transferred to a recording chamber, and the head cap that connects the
animal to recording system was placed. Following 5 min
of acclimatization to the chamber environment, baseline
measurement of the brain activity was taken via the implanted electrodes for 2 min (after amplification using a
Grass instruments Model 55 preamplifier a Molecular Devices Digidata 1550 A/D converter sampling rate of 4 kHz).
Following this, a clip of moderate strength (stress) was
placed on the middle of the tails of animals. Tails were
covered with a paper towel or a clean cotton rag before
the paper clip was applied to prevent pain and local
damage of the tissue. This stressor was applied for 2 min,
and at the end of this time, the clip was removed. The
recording continued for further 2 min in the absence of
stress. This procedure is not considered to be painful.
Spectral analysis of amygdala recordings
Recordings were analyzed using MATLAB 2018a
(MathWorks). To visualize the spectral responses during
the stressor, the local field potential (LFP) signal was
convolved with complex Morlet wavelets and then
squared, thereby extracting the frequency-specific power
and transforming the signal into a time-frequency representation. The Morlet wavelets were constructed with
seven wavelet oscillations and center frequencies in
10-Hz steps from 1 to 500 Hz (Tallon-Baudry et al., 1997).
In the spectrograms, low power is represented by blue
colors and high power by dark red. The recordings were
also visually checked for spikes that when filtered may
eNeuro.org
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produce artifacts resembling fast ripples (Bénar et al.,
2010).
To examine the average responses of the two groups
across the entire HFO range, the recordings were high
pass filtered at ⬎120 Hz. Power spectra were then generated for the baseline and stress response. The two
spectra were then subtracted and normalized. For the five
rats analyzed in each group, sham and TBI, these subtracted and normalized spectra were then averaged to
generate an aggregate response for these two groups.
Phase amplitude coupling data analysis
Analyses were done using MATLAB 2018a (MathWorks). Raw signals were convoluted with complex Morlet wavelets with seven wave oscillations. The phase of
low frequencies (wavelets centered at 1–21 Hz in steps of
2 Hz) was extracted by calculating the convolved vector in
relation to the real axis. The amplitude of higher frequencies (centered at 20 –500 Hz in steps of 10 Hz) was found
by squaring the result of convolution (Tallon-Baudry et al.,
1997). Peaks of high power (⬎2 SD) during the stress
epoch in band-specific peaks within the wavelet spectral
bandwidth were found. One-second windows centered
around each peak were analyzed for their strength of
phase-amplitude coupling using the modulation index
(MI; Tort et al., 2010). A window length of 1 s was chosen
because HFO events were ⬃1 s in duration and occurred
sporadically during stress. The normalized mean highfrequency amplitude value at each low-frequency phase
bin, known as the pj value, for each high-power window
for all rats in each drug condition were pooled. Pooling
these 1-s windows found over the 2-min stress epoch
gives a more robust estimation of coupling than simply
calculating the MI over a longer time window, especially
during the drug condition, in which the signal-to-noise
ratio is much lower due to reduction in occurrence and
amplitude of HFO events. The pooled normalized values
were used to calculate the MI at each frequency pairing
during each drug condition and are represented in comodulograms showing preferred frequency of coupling in
Figure 7. Surrogate analyses were performed via shuffling
the phase of one window with the amplitude of another
window (n ⫽ 10,000) for each frequency pairing and then
calculating the MI. Also, oscillation-triggered comodulograms were created by summing 1 s of raw recordings
centered around these peaks to reveal underlying rhythmic low-frequency activity (Dvorak and Fenton, 2014;
Samiee and Baillet, 2017) as shown in Figure 8. The
custom MATLAB scripts used are available on request.
Reagents
Bisindolylmaleimide (BIS; PKC antagonist), PMA (PKC
activator), forskolin (adenyly cyclase activator), and H89
[protein kinase A (PKA) antagonist] were obtained from
Sigma-Aldrich Co. CRF and CP 154526 were obtained
from Tocris Biosciences. Di-4-ANEPPS stock solution
was prepared in alcohol and cremophore-EL solution,
which can be stored at 4°C for two months. FBS and
ACSF were added on the day of the experiment. CRF
stock was dissolved in HBSS and Milli-Q water mixture.
Forskolin, H89, BIS, antalarmin, and PMA stock solutions
March/April 2019, 6(2) e0334-18.2019
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were prepared in dimethyl sulfoxide (DMSO). All the stock
solutions were made 1000 times more concentrated than
working concentrations.
Statistical analysis
All statistical evaluations were done using StatView
software. For the VSDI data, two-way ANOVAs were conducted to compare the neuronal responses after the application of BIS, PMA, forskolin, and H89 in the PCtx
layers in response to LOT stimulation. CRF responses
were analyzed by a repeated measures ANOVA in which
the responses to CRF in the absence of drugs served as
the within group measure. Follow-up comparisons were
conducted using Fisher’s protected least significance difference test to maintain p at 0.05. A 2 analysis was used
to evaluate the seizure behaviors between sham and TBI
rats. A Kolmogorov test for differences in distributions of
the baseline subtracted power spectra was used to statistically analyze the sham and TBI averaged spectra (Fig.
5D).

Results
The inhibitory effect of the stressor hormone/neurotransmitter CRF in the PCtx of rats becomes excitatory
after kindling (Narla et al., 2016). We hypothesized that
CRF may change its signaling after the induction of TBI
and that this change may exacerbate stress responses
and elicit epileptiform activity. First, we used VSDI which
shows how PCtx circuitry responds to a stimulus given to
the LOT and whether CRF alters this circuit activation. The
PCtx is a convenient and relevant structure to assay this
activity as it readily supports seizures and has strong
interconnections with other limbic regions such as the
amygdala, hippocampus, and entorhinal cortex (EC).
Each of these are known to be involved in the stressor
responses. In a previous report, it has been shown (Birjandian et al., 2013) that in the non-brain-injured rat, the
network response is characterized by three phases of the
response in Layers II, III, and DEn (Fig. 1A, top row). Layer
II is activated first followed by the activation of the DEn
and then the deactivation of the Layer III. This is done by
stimulation of LOT with different frequencies ranging from
5 to 80 Hz (Fig. 1B–D). In sham rats, CRF reduced the
excitability of Layer II and DEn and the deactivation of
Layer III (Fig. 1A, bottom row, B–D). However, after TBI,
CRF alters this network activation and increases the excitability but with important differences in the pattern of
activity seen in non-injured animals. Ipsilateral to the injury
there was little to no DEn response observed, and the
deactivation of Layer III neurons flips polarity becoming
activated (Fig. 1E, top row, F–H). We have provided evidence in the past that this deactivation is caused by the
disinhibition of the Layer III interneurons and relies on the
activation of neurons in the DEn. Despite the activation of
the interneurons in Layer III, CRF application still increased the excitability of Layer II pyramidal cells which
are the primary projection neurons of this circuit (Fig. 1E,
bottom row, F–H). Thus, after brain injury, CRF increased
circuit activation, an effect opposite to non-brain-injured
rats. CRF was also able to increase circuit activation on
the contralateral PCtx. However, the pattern of circuit
eNeuro.org
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A Non-brain injured rat

Figure 1. continued
over the range of stimulation frequencies used in piriform cortical
slices from TBI rats to activate the circuit; ⴱp ⬍ 0.05. n ⫽ 9 slices
from seven rats. No response is observed from interneurons of
DEn. Arrows in panels indicate the orientation of slice. D, dorsal;
V, ventral; M, medial; L, lateral. Red indicates highest ⌬F/F;
orange, yellow and green indicate medium ⌬F/F; blue a reduction in ⌬F/F.

Control

D DEn
L

M

II

V

5 of 13

III

CRF 100 nM

E

Control
CRF
*

*

*

01020 40 60 80
Pulses per sec (Hz)

D

Layer III

0
-1
-2
-3
-4
-5

*

*
*

*

Den

Normalized ΔF/F

C

Layer II

7
6
5
4
3
2
1
0

Normalized ΔF/F

Normalized ΔF/F

B

5
4
3
2
1
0

01020 40 60 80
Pulses per sec (Hz)

*
*
*

01020 40 60 80
Pulses per sec (Hz)

raumatic brain injured rat (ipsilateral to injury)
Control

Control

D DEn
L

M
V

III

II
III

II

II
III

CRF 100 nM

Normalized ΔF/F

Layer II
8
7
6
5
4
3
2
1
0

Control
CRF

*
*

*
*

0 10 20

40

60

G4
Normalized ΔF/F

F

Layer III
*

3

*
*

2
1

*

0

80

0 10 20

40

60

80

Figure 1. CRF application increased the activity of the PCtx in
TBI rat. A, Representative images showing activation of PCtx
from sham rats, without (top) or with CRF (100 nM; bottom). Each
image was taken at the same time interval [2 (during stimulation),
3, and 5 s]. B–D, Quantification of CRFR1 activation shows that
the activity of Layer II pyramidal cells and interneurons of DEn
are decreased while the activity of Layer III interneurons is
increased in non-brain-injured animals over the range of stimulation frequencies used to activate the circuit; ⴱp ⬍ 0.05; n ⫽ 5
slices from four rats. E, Representative images showing activation of the layers of ipsilateral PCtx from brain-injured rats,
without (top) or with CRF bottom). F, G, Quantification of CRFR1
activation shows that the activity of Layer II pyramidal cells is
increased while the activity of Layer III interneurons is decreased
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activation was not the same as on the contralateral side
and was similar to sham controls where Layers II, III, and
the DEn were all involved (Fig. 2). Nevertheless, CRF
increased the excitability in these assays as well. The
activity of CRF was blocked by the CRFR1 antagonist,
antalarmin (100 nM; Fig. 3), on the both ipsilateral and
contralateral sides. Previous work has shown that the
CRF antagonists have no effect on their own in this assay
(Narla et al., 2016).
In the TBI rat, inhibition of PKC by BIS or its activation
by PMA did not block or mimic the effects of CRF (Fig.
4A–D). However, forskolin, an activator of adenylyl cyclase that mimics the effect of activated G␣s, produced
responses similar to that of CRF. Forskolin activity was
antagonized by the PKA inhibitor H89 (Fig. 4E,F). This is in
contrast to sham control rats where CRFR1 couples to
G␣q/11 and thus activates PKC (also see Narla et al., 2015,
2016). Thus, TBI alters the effects of CRF on network
behavior likely by an alteration in G-protein coupling.
In contrast to mice, rats in this TBI model rarely develop
spontaneous seizures (Bolkvadze and Pitkänen, 2012).
Nevertheless, as reported in the past (Pitkänen et al.,
2009, 2014), injured rats do have epileptiform activity. We
wanted to determine whether TBI rats would respond to
an acute stressor differently than sham rats and whether
electrophysiological responses from the stressor responsive nuclei, the amygdala (which is strongly connected to
the PCtx), may be affected. We used the acute tail pinch
to deliver a stressor to rats while recording from the
amygdala (Gibb et al., 2008). A trial began with a baseline
recording for 2 min in the absence of the stressor followed
by 2-min recording in the presence of the stressor ending
by a 2-min recording in the absence of the stressor. We
were also particularly interested to see whether HFOs
(ripples ⬎ 120 ⬍ 250 Hz) and fast ripples (⬎250 Hz)
became more prevalent as the increased occurrence of
latter wave forms are associated with epileptic activity
(Jefferys et al., 2012). We found that in sham rats the
responses to this stressor were mild (Fig. 5A) and highfrequency content was much lower (Fig. 5E), although the
rats were equally agitated and attempted to remove the
clip from their tail in response to the stressor. In Figure 5B,
we show a typical electrical response from a TBI rat
recorded from the amygdala during a tail pinch stressor.
This electrophysiological response in the TBI rats was
accompanied by stage 2–3 seizures (Racine scale; av 2.5
⫾ 0.4 SD, n ⫽ 5 rats; Racine et al., 1988). Sham rats did
not have any seizure behaviors (p ⬍ 0.01, 2 analysis). In
Figure 5C, we show a sub sample of the response in
Figure 5B (150 ms). The unfiltered sample is black, while
the band passed 120 –250 Hz is red, and high pass filtered
eNeuro.org
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Figure 2. Application of CRF increased contralateral PCtx activity in brain-injured rats. CRFR1 mediated these effects. A, Representative images showing activation of layers of contralateral piriform cortical slices from brain-injured rats, without (top) or with CRF
perfusion before recording (bottom). B–D, Quantification of CRFR1 activation shows that the activity of Layer II pyramidal cells and
interneurons of DEn are increased while the activity of Layer III interneurons is decreased over the range of stimulation frequencies
used in contralateral piriform cortical slices from brain-injured rats to activate the circuit; ⴱp ⬍ 0.01; n ⫽ 8 slices from six rats.

⬎250 Hz is blue, showing both ripples and fast ripples,
respectively. In Figure 5D, we show the averaged power
spectra of the high passed filtered recordings (⬎120 Hz)
from five sham TBI and five TBI rats. This was done by
subtracting the power spectra of the baseline from the
spectra during stressor responses. The baseline corrected spectra were then normalized and averaged. We
found little or no increase in power at high frequencies in
the sham rats, but in TBI rats, the power increased by
⬃2.5-fold (particularly above 250 Hz, the distributions of
these two spectra showed they were not the same p ⬍
0.001, Kolmogorov–Smirnov test). A spectral analysis of
the entire response using a Morlet wavelet transform
revealed a small increase in power at frequencies up to
100 Hz in the sham rats but HFOs (ripples and fast ripples)
were rare, although some were observed (Fig. 5E). This
was very different in TBI rats (Fig. 5F), where both kinds of
ripples occurred during the application of the stressor.
Figure 5F, inset, shows that the wavelet analysis over a
500-ms window.
In Figure 6, we show a typical electrophysiological response from a TBI rat and its attenuation by the CRFR1
antagonist CP 154526 (1.5 h after an intraperitoneal injection of 50 mg/kg). All rats also exhibited no seizure behavior. The accompanying Morlet wavelet analyses
showed a marked attenuation of activity in both the high
March/April 2019, 6(2) e0334-18.2019

and low frequency 3 h after the injection and this was
reversed 24 h later.
We next examined whether the high-frequency activity
was phase/amplitude locked to any particular frequencies. In Figure 7, we show a summary of the phase
amplitude coupling (Tort et al., 2010) between lowfrequency activity (binned on x-axis) versus high frequencies (binned on the y-axis) in the signals before, during,
and after CRFR1 antagonist treatment. The averaged MIs
from all five rats are shown in this analysis and are color
coded as a heat map on the left. The control responses
showed that in range of 4 – 8 Hz, there was high coupling
in both the ripple and fast ripple bands. This was particularly prominent between for the fast ripple whose MIs
were the largest (MI ⫽ 2.05 ⫻ 10⫺3 vs surrogate MI ⫽ 5.47
⫻ 10⫺5). In the CP 154526-treated rats, no coupling was
only observed between the  band and high-frequency
bands. These MIs calculated in the presence of antagonist were below chance, as calculated by surrogate analyses of shuffling (MI ⫽ 1.28 ⫻ 10⫺3 vs surrogate MI ⫽
4.11 ⫻ 10⫺3). After recovery, the coupling between 4 and
8 Hz and the ripple and fast ripple bands were again
present (MI ⫽ 1.56 ⫻ 10⫺3 vs surrogate MI ⫽ 2.77 ⫻
10⫺5). There was no preferred phase angle in both control
and washout recordings.
Finally, to confirm this analysis, we also calculated an
oscillation-triggered comodulogram (Dvorak and Fenton,
eNeuro.org
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Figure 3. CRFR1 mediate CRF responses in brain-injured PCtx.
A, Representative images of the activation of the PCtx layers in
slices at differing time points before (top) and after the application of CRF (bottom) in the presence of the CRFR1 antagonist
antalarmin. B, C, Quantification of CRFR1 activation in the presence of antalarmin in Layer II and Layer III of ipsilateral PCtx; n ⫽
6 slices from five rats.

2014; Samiee and Baillet, 2017) for the pooled data before, during, and after CRFR1 antagonism. The crests of
fast ripple activity aligned at a slow oscillation of ⬃0.2 s
between crests, or a 5-Hz wave (). This analysis confirms
the observations using the MI described by Tort et al.
(2010).

Discussion
TBI is a major risk factor in the development of epilepsy
(Xu et al., 2017). PTSD and TBI are often comorbid as
brain injuries are often associated with traumatic experiences (Ohry et al., 1996; Hickling et al., 1998; Levin et al.,
2001; Greenspan et al., 2006; Gaylord et al., 2008; Hoge
et al., 2008; Bryant, 2011). To date, a few mechanisms
have been proposed to account for the high association
of PTSD and the development of epilepsy such as upregulated glutamate neurotransmission, axonal damage,
and compromised interneuronal circuits (Guerriero et al.,
2015). CRF has been implicated in several brain disorders
such as anxiety, stress, depression, and neuropathic pain.
Clinical studies have shown that increased concentrations
of CRF in the CSF are associated with PTSD (Post et al.,
1982) and several studies have found altered hypothalamic pituitary adrenal (HPA) axis and CRF function in
PTSD (Mason et al., 1986; Smith et al., 1989; Pitman and
Orr, 1990; Yehuda et al., 1993). Consistent with these
March/April 2019, 6(2) e0334-18.2019
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reports, studies in humans showed a chronic increase in
CRF release following stress exposure (Dallman and
Jones, 1973). In TBI rats, we showed that CRF exhibited
excitatory effects in the PCtx, a region that has strong
interconnections with most limbic regions. Excitatory activity of CRF was wide spread, occurring on both the
injured and uninjured sides. Therefore, these changes in
CRF activity have a wide impact that either originate in the
PCtx or involve changes that associate other limbic regions to produce the electrophysiological responses we
observed in the amygdala.
Importantly, our observations indicate that pathologic
mechanisms that accompany brain injury make the brain
susceptible to stressor-induced increases in the excitability of the amygdala. In particular, the phase coupling
between the pathophysiological HFOs and  oscillations
seem important as this coupling may aid in the spread of
the high-frequency activity contributing to epileptogenesis. Indeed, it has been noted in previous studies that
HFOs have a surprising ability to spread and exhibit high
coherence across much larger volumes than one might
expect (Haufler and Pare, 2014). These findings also provide insight into why those who have suffered TBI and
PTSD have a 3-fold increase in the incidence to develop
epilepsy, which is often pharmacoresistant (Hitiris et al.,
2007).
For over 15 years, HFOs have been the subject of great
interest. Here, we have examined HFOs that occur above
120 Hz (above high ␥) to the 500 Hz. HFOs (ripples)
between 120 and 250 Hz are thought to be, in general,
physiologic, whereas those occurring above 250 Hz (fast
ripples) are generally considered to be pathologic HFOs
(pHFOs), supporting the generation of epileptic seizures
(Bragin et al., 1999; Jefferys et al., 2012). This view is by
no means settled and other phenomena may also need to
be considered as contributing to the pathophysiological
endpoints. These include whether they are bursting (like
observed here) or steady state HFOs, phase locked to a
behavioral or electrical event and their location (Jefferys
et al., 2012). Also, it has been reported that ripples are
associated with epileptic behavior in animal models (Shiri
et al., 2016) as well as in humans (Weiss et al., 2016). The
other issue is whether pHFOs are an epiphenomena or
causative of the epileptic state. Evidence that the latter
may be true comes from work showing that during the
transition period from the latent to the chronic phase in
the pilocarpine model of mesial temporal lobe epilepsy,
there is an increased incidence of HFO activity in the EC
and CA3 region of the hippocampus (Salami et al., 2014)
and the block of their occurrence with the AED levetiracetam impeded seizure genesis. Here, we have recorded
HFOs from the amygdala, a region of the brain that readily
supports the development of seizures (McIntyre et al.,
2002). Thus, the occurrence of fast ripples in this region
would be predicted to be supportive of the development
of seizure activity in PCtx. Previously, HFOs have been
isolated in the amygdala and associated limbic regions
(DEn, central amygdala, EC, and PCtx; Ponomarenko
et al., 2003; Haufler and Pare, 2014; Salami et al., 2014).
In general, these studies have found that HFOs occur
eNeuro.org
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Figure 4. PKA and PKC antagonism in ipsilateral and contralateral PCtx in the presence of CRF. A, Quantification of the effect of BIS
on CRFR1 activation in ipsilateral piriform cortical slices from brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 8 slices from eight rats/group. B,
Quantification of the effect of the PKC inhibitor, PMA, on CRF-mediated activation of CRFR1 in ipsilateral piriform cortical slices from
brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 9 slices from eight rats/group. C, Quantification of the effect of the PKA antagonist H89 on
CRF-mediated activation of CRFR1 in ipsilateral piriform cortical slices from brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 9 slices from seven
rats/group. D, Quantification of the effect of forskolin, an adenylate cyclase activator with or without subsequent administration of H89
on ipsilateral piriform cortical slices from brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 8 slices from six rats/group. E, Quantification of the
effect of forskolin (an adenylyl cyclase activator) with or without subsequent administration of H89, on CRFR1 activation in
contralateral piriform cortical slices from brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 7 slices from six rats/group. F, Quantification of the
effect of the PKA inhibitor H89 on CRF-mediated activation of CRFR1 in contralateral piriform cortical slices from brain-injured
animals; ⴱp ⬍ 0.05, n ⫽ 6 slices from six rats/group. G, Quantification of the effect of the PKC antagonist BIS on CRF-mediated
activation of CRFR1 in contralateral piriform cortical slices from brain-injured animals; ⴱp ⬍ 0.05, n ⫽ 6 slices from six rats/group.

regionally in a highly synchronous manner so that HFOs
occurring in one region are highly correlated with occurrences in other regions. In fact, it was noted that an
apparently unusual property of HFOs relative to all other
fast frequency (␥) LFPs was their high coherence (Haufler
and Pare, 2014), although this was less when ipsilateral
and contralateral structures were compared. LFP coherence usually decreases with distance, and this reduction
is quite steep for their fast components (Steriade et al.,
1996; Collins et al., 2001). In addition, the main difference
March/April 2019, 6(2) e0334-18.2019

between what was observed in past reports and our
findings is that the fast ripples recorded here were highly
phasic locked to  oscillations. A recent study has shown
that high-power low-frequency oscillations coupled to
HFOs could be readily identified in a brain region of
patients with pharmacoresistant epilepsy and when this
region was subsequently removed, better clinical outcomes were seen (Cotic et al., 2016). This supports the
idea that the HFO/ cross-frequency coupling seems to
be highly epileptogenic.
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Figure 5. Stress induces a larger electrographic response in the amygdala of TBI than in sham rats A, Recording of TBI rat amygdala
response from a sham operated rat showed only small electrographic response to a tail inch stress, while in B, TBI-injured rats showed a
large increase in electrical activity. C, A 100-ms sample of a response where ripples (red band pass filtered ⬎120 ⬍ 250 Hz) and fast ripples
(blue high pass filtered ⬎250 Hz) are clearly visible. D, Mean normalized power spectra of sham (n ⫽ 5) and TBI (n ⫽ 5). HFOs compared
to lower frequencies showed a 2.5-fold change in power in TBI rats, but little change in sham rats. E, F, A comparison of frequency content
of sham rats’ response using Morlet wavelet analysis shows that sham rats have only small responses to the stressor, while in TBI rats, large
increases in electrical activity during stressor. The inset Morlet using a smaller window shows well-resolved fast ripple activity (ⴱ marks
approximate time from which the window was obtained; white scale bar is 100 ms).

While it clear that stress generates HFOs, how this
occurs is not known. It seems likely that CRF is influencing the activity of the local circuit neurons to produce
these network effects but exactly how this occurs is not
known. CRF has a wide range of activity on both excitatory and inhibitory neurons of the PCtx in naïve rats. In
particular, it has highly complex effects on interneurons.
In some cases, CRF application converted slow firing
interneurons to fast firing ones, in others fast firing was
converted to slow while on another population CRF had
no effects (Narla et al., 2015). Further studies will be
required to provide insight into how CRF affects these
neurons after TBI.
March/April 2019, 6(2) e0334-18.2019

There is also an added complexity here, as ipsilateral to
the injury, interneurons of Layer III became excitable while
the interneurons of DEn were silent. We have ruled out cell
loss and the degeneration of axons as a cause of this
change in the activation pattern (unpublished observations). One possibility that may explain this is the observation that suggests interneurons become functionally
silent after an insult. Evidence for this interpretation
comes from a study where the perforant path model of
temporal lobe epilepsy was used. Sloviter (1987) described disruption of functional inhibition in the presence
of viable interneurons and functionally active GABAA receptors in the dentate gyrus and CA1 areas of hippocameNeuro.org
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pus (Sloviter, 1987, 1991). Similar observations were also
observed by two other studies showing no loss of
GABAergic interneurons (Bekenstein and Lothman, 1993;
Lothman et al., 1996) but a reduction in inhibitory activity.
This paradox has been described as a “dormancy of
interneurons” where the inhibitory cells became quiescent
and disconnected. Similar observations were reported in
tetanus toxin model of epilepsy where evidence for the
existence of functionally dormant interneurons was
shown (Jefferys and Traub, 1998). To what degree this
may occur in the BLA is not known.
Our current findings suggest that CRFR1 antagonists
may have a clinical importance as antiepileptic drugs.
CRFR1 antagonists have long been under investigation
for treating stress related disorders such as anxiety and
depression, although the results have not been promising (Zorrilla and Koob, 2004; Valdez, 2009). No clinical
study has investigated or argued for the use of CRFR1
antagonists in post TBI to prevent epilepsy. Also, it has
been observed that exogenously applied CRF induced
excitotoxicity of interneurons (Aldenhoff et al., 1983;
Bishop and King, 1992), which suggests that CRFR
antagonists may be effective in providing neuroprotection in the hippocampus following seizure (Maecker
et al., 1997) and after cerebral ischemia (Lyons et al.,
1991).
In summary, our findings provide a mechanism by
which individuals affected by TBI develop stressassociated epilepsy. Molecular mechanisms following
brain injury alter the function of stress hormone/neurotransmitter that causes a widespread increase in excitability. In particular, the generation of fast ripples during
the response and their phase coupling to the  oscillations
could be particularly epileptogenic.
March/April 2019, 6(2) e0334-18.2019
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